GALAPAGOS NV-SPON ADR (GLPG) Fundamental Analysis & Valuation

NASDAQ:GLPG • US36315X1019

Current stock price

28.84 USD
-0.09 (-0.31%)
At close:
29.44 USD
+0.6 (+2.08%)
Pre-Market:

This GLPG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. GLPG Profitability Analysis

1.1 Basic Checks

  • In the past year GLPG was profitable.
  • GLPG had a negative operating cash flow in the past year.
  • In multiple years GLPG reported negative net income over the last 5 years.
  • GLPG had a negative operating cash flow in each of the past 5 years.
GLPG Yearly Net Income VS EBIT VS OCF VS FCFGLPG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

1.2 Ratios

  • With an excellent Return On Assets value of 9.42%, GLPG belongs to the best of the industry, outperforming 93.42% of the companies in the same industry.
  • GLPG's Return On Equity of 9.92% is amongst the best of the industry. GLPG outperforms 92.26% of its industry peers.
  • GLPG has a better Return On Invested Capital (12.70%) than 95.36% of its industry peers.
Industry RankSector Rank
ROA 9.42%
ROE 9.92%
ROIC 12.7%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GLPG Yearly ROA, ROE, ROICGLPG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 -10

1.3 Margins

  • GLPG's Profit Margin of 28.85% is amongst the best of the industry. GLPG outperforms 94.39% of its industry peers.
  • GLPG has a better Operating Margin (47.04%) than 99.23% of its industry peers.
  • Looking at the Gross Margin, with a value of 97.33%, GLPG belongs to the top of the industry, outperforming 96.71% of the companies in the same industry.
  • In the last couple of years the Gross Margin of GLPG has declined.
Industry RankSector Rank
OM 47.04%
PM (TTM) 28.85%
GM 97.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.64%
GM growth 5YN/A
GLPG Yearly Profit, Operating, Gross MarginsGLPG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100 150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. GLPG Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so GLPG is still creating some value.
  • GLPG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GLPG Yearly Shares OutstandingGLPG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
GLPG Yearly Total Debt VS Total AssetsGLPG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 7.77 indicates that GLPG is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 7.77, GLPG is doing good in the industry, outperforming 79.50% of the companies in the same industry.
  • GLPG has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • GLPG has a Debt to Equity ratio (0.00) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 7.77
ROIC/WACC1.6
WACC7.93%
GLPG Yearly LT Debt VS Equity VS FCFGLPG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B

2.3 Liquidity

  • GLPG has a Current Ratio of 20.15. This indicates that GLPG is financially healthy and has no problem in meeting its short term obligations.
  • GLPG has a better Current ratio (20.15) than 95.16% of its industry peers.
  • A Quick Ratio of 20.00 indicates that GLPG has no problem at all paying its short term obligations.
  • GLPG has a better Quick ratio (20.00) than 95.16% of its industry peers.
Industry RankSector Rank
Current Ratio 20.15
Quick Ratio 20
GLPG Yearly Current Assets VS Current LiabilitesGLPG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. GLPG Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 334.82% over the past year.
  • GLPG shows a strong growth in Revenue. In the last year, the Revenue has grown by 280.53%.
  • GLPG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.97% yearly.
EPS 1Y (TTM)334.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3023.68%
Revenue 1Y (TTM)280.53%
Revenue growth 3Y58.87%
Revenue growth 5Y15.97%
Sales Q2Q%1093.16%

3.2 Future

  • The Earnings Per Share is expected to decrease by -23.16% on average over the next years. This is quite bad
  • Based on estimates for the next years, GLPG will show a very negative growth in Revenue. The Revenue will decrease by -30.71% on average per year.
EPS Next Y-150.44%
EPS Next 2Y-64.81%
EPS Next 3Y-30.23%
EPS Next 5Y-23.16%
Revenue Next Year-0.05%
Revenue Next 2Y-2.62%
Revenue Next 3Y-0.5%
Revenue Next 5Y-30.71%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GLPG Yearly Revenue VS EstimatesGLPG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M 1B
GLPG Yearly EPS VS EstimatesGLPG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4

More info and screens

Find the best growth stocksShow best growing peers

2

4. GLPG Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 5.16, the valuation of GLPG can be described as very cheap.
  • 98.45% of the companies in the same industry are more expensive than GLPG, based on the Price/Earnings ratio.
  • GLPG is valuated cheaply when we compare the Price/Earnings ratio to 24.75, which is the current average of the S&P500 Index.
  • The Forward Price/Earnings Ratio is negative for GLPG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 5.16
Fwd PE N/A
GLPG Price Earnings VS Forward Price EarningsGLPG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GLPG Per share dataGLPG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • GLPG's earnings are expected to decrease with -30.23% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-64.81%
EPS Next 3Y-30.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GLPG Dividend Analysis

5.1 Amount

  • No dividends for GLPG!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GLPG Fundamentals: All Metrics, Ratios and Statistics

GALAPAGOS NV-SPON ADR

NASDAQ:GLPG (3/30/2026, 8:05:26 PM)

Premarket: 29.44 +0.6 (+2.08%)

28.84

-0.09 (-0.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-24
Earnings (Next)N/A
Inst Owners25.24%
Inst Owner Change-0.24%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.90B
Revenue(TTM)1.11B
Net Income(TTM)320.88M
Analysts52.22
Price Target37.13 (28.74%)
Short Float %1.85%
Short Ratio6.81
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9817.73%
Min EPS beat(2)-19965.4%
Max EPS beat(2)329.9%
EPS beat(4)1
Avg EPS beat(4)-5598.11%
Min EPS beat(4)-19965.4%
Max EPS beat(4)329.9%
EPS beat(8)4
Avg EPS beat(8)-2634.25%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)487.53%
Min Revenue beat(2)-2.86%
Max Revenue beat(2)977.92%
Revenue beat(4)2
Avg Revenue beat(4)242.29%
Min Revenue beat(4)-10.27%
Max Revenue beat(4)977.92%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.89%
EPS NQ rev (1m)-16.45%
EPS NQ rev (3m)-16.23%
EPS NY rev (1m)-36.8%
EPS NY rev (3m)-34.04%
Revenue NQ rev (1m)-0.4%
Revenue NQ rev (3m)-0.4%
Revenue NY rev (1m)-0.46%
Revenue NY rev (3m)-0.5%
Valuation
Industry RankSector Rank
PE 5.16
Fwd PE N/A
P/S 1.49
P/FCF N/A
P/OCF N/A
P/B 0.51
P/tB 0.51
EV/EBITDA N/A
EPS(TTM)5.59
EY19.38%
EPS(NY)-2.82
Fwd EYN/A
FCF(TTM)-4.73
FCFYN/A
OCF(TTM)-4.49
OCFYN/A
SpS19.38
BVpS56.39
TBVpS56.38
PEG (NY)N/A
PEG (5Y)N/A
Graham Number84.22
Profitability
Industry RankSector Rank
ROA 9.42%
ROE 9.92%
ROCE 16.08%
ROIC 12.7%
ROICexc 161.69%
ROICexgc 162.23%
OM 47.04%
PM (TTM) 28.85%
GM 97.33%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.64%
GM growth 5YN/A
F-Score6
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1.25%
Interest Coverage 1127.48
Cash Conversion N/A
Profit Quality N/A
Current Ratio 20.15
Quick Ratio 20
Altman-Z 7.77
F-Score6
WACC7.93%
ROIC/WACC1.6
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)13.02%
Cap/Sales(5y)12.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)334.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3023.68%
EPS Next Y-150.44%
EPS Next 2Y-64.81%
EPS Next 3Y-30.23%
EPS Next 5Y-23.16%
Revenue 1Y (TTM)280.53%
Revenue growth 3Y58.87%
Revenue growth 5Y15.97%
Sales Q2Q%1093.16%
Revenue Next Year-0.05%
Revenue Next 2Y-2.62%
Revenue Next 3Y-0.5%
Revenue Next 5Y-30.71%
EBIT growth 1Y377.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year27.8%
EBIT Next 3Y20.58%
EBIT Next 5Y15.02%
FCF growth 1Y32.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.55%
OCF growth 3YN/A
OCF growth 5YN/A

GALAPAGOS NV-SPON ADR / GLPG Fundamental Analysis FAQ

What is the fundamental rating for GLPG stock?

ChartMill assigns a fundamental rating of 4 / 10 to GLPG.


Can you provide the valuation status for GALAPAGOS NV-SPON ADR?

ChartMill assigns a valuation rating of 2 / 10 to GALAPAGOS NV-SPON ADR (GLPG). This can be considered as Overvalued.


What is the profitability of GLPG stock?

GALAPAGOS NV-SPON ADR (GLPG) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for GLPG stock?

The Price/Earnings (PE) ratio for GALAPAGOS NV-SPON ADR (GLPG) is 5.16 and the Price/Book (PB) ratio is 0.51.